EORTC protocol 22042 - 26042

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma : a Phase II and observation study
Trial StatusRecruiting
DatesDate of activation: 17-Dec-07
Data management at EORTCFull
Phase2
Randomized trial
TypeAdjuvant
Targeted Sample sizeEORTC Groups: 54 - All Groups: 54
Number of steps1
Drug
Study StaffDamien Weber (Study Coordinator) - Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie, Geneve
Laurence Collette (Statistician) - EORTC Headquarters, Brussels
Isabelle Meulders (Data Manager) - EORTC Headquarters, Brussels
Denis Lacombe (Coordinating Physician) - EORTC Headquarters, Brussels
Emad Shash (Coordinating Physician) - EORTC Headquarters, Brussels
Julie Hermans (Project Manager) - EORTC Headquarters, Brussels, julie.hermans( at )eortc.be, +32 27741673
Type of cancerBrain
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
EORTC Brain Tumor Group
Centers authorized by EORTC Cliniques Universitaires St. Luc (Brussels, Belgium) - Inst. 121
CHU de Lyon - Centre Hospitalier Lyon Sud (Pierre-Benite (lyon), France) - Inst. 194
Centre Antoine Lacassagne (Nice, France) - Inst. 218
Centre Leon Berard (Lyon, France) - Inst. 227
Universitaetsklinikum Leipzig (Leipzig, Germany) - Inst. 3220
Universita Di Torino (Torino, Italy) - Inst. 730
Ospedale Sant Anna (Como, Italy) - Inst. 884
Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (barcelona), Spain) - Inst. 381
Institut Catala d'Oncologia - ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L'Hospitalet de Llobregat, Spain) - Inst. 6225
Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie (Geneve, Switzerland) - Inst. 451
Inselspital (Bern, Switzerland) - Inst. 454
Erasmus MC - Daniel den Hoed Cancer Center (Rotterdam, The Netherlands) - Inst. 302
Vrije Universiteit Medisch Centrum (Amsterdam, The Netherlands) - Inst. 308
Dr. Bernard Verbeeten Instituut (Tilburg, The Netherlands) - Inst. 341
Academisch Medisch Centrum - Universiteit van Amsterdam (Amsterdam, The Netherlands) - Inst. 342
Maastro Clinic - Maastricht Radiation Oncology (Maastricht, The Netherlands) - Inst. 4900
University Hospital Birmingham - Queen Elisabeth Medical Centre (Birmingham, United Kingdom) - Inst. 629
Cambridge University Hospital NHS - Addenbrookes Hospital (Cambridge, United Kingdom) - Inst. 632
NHS Lothian - Western General Hospital (Edinburgh, United Kingdom) - Inst. 641
Nottingham University Hospitals NHS Trust - City Hospital campus (Nottingham, United Kingdom) - Inst. 6998
Guy's and St Thomas' NHS - St Thomas Hospital (London, United Kingdom) - Inst. 7013
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00626730
EudraCT2005-005551-18
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section